|
1
|
Znaor A, Lortet-Tieulent J, Laversanne M,
Jemal A and Bray F: International variations and trends in renal
cell carcinoma incidence and mortality. Eur Urol. 67:519–530. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ciardiello C, Leone A and Budillon A: The
crosstalk between cancer stem cells and microenvironment is
critical for solid tumor progression: The significant contribution
of extracellular vesicles. Stem Cells Int. 2018:63921982018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prager BC, Xie Q, Bao S and Rich JN:
Cancer stem cells: The architects of the tumor ecosystem. Cell Stem
Cell. 24:41–53. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lucarelli G, Galleggiante V, Rutigliano M,
Vavallo A, Ditonno P and Battaglia M: Isolation and
characterization of cancer stem cells in renal cell carcinoma.
Urologia. 82:46–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiao X, Rizvanov AA, Cristofanilli M,
Miftakhova RR and Pestell RG: Breast cancer stem cell isolation.
Methods Mol Biol. 1406:121–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jensen SS, Meyer M, Petterson SA, Halle B,
Rosager AM, Aaberg-Jessen C, Thomassen M, Burton M, Kruse TA and
Kristensen BW: Establishment and characterization of a tumor stem
cell-based glioblastoma invasion model. PLoS One. 11:e01597462016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bussolati B, Bruno S, Grange C, Ferrando U
and Camussi G: Identification of a tumor-initiating stem cell
population in human renal carcinomas. FASEB J. 22:3696–3705. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhong Y, Guan K, Guo S, Zhou C, Wang D, Ma
W, Zhang Y, Li C and Zhang S: Spheres derived from the human
SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem
cells. Cancer Lett. 299:150–160. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang B, Huang YJ, Yao ZJ, Chen X, Guo SJ,
Mao XP, Wang DH, Chen JX and Qiu SP: Cancer stem cell-like side
population cells in clear cell renal cell carcinoma cell line 769P.
PLoS One. 8:e682932013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang L, Xie G, Fan Q and Xie J: Activation
of the hedgehog-signaling pathway in human cancer and the clinical
implications. Oncogene. 29:469–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ruch JM and Kim EJ: Hedgehog signaling
pathway and cancer therapeutics: Progress to date. Drugs.
73:613–623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gorojankina T: Hedgehog signaling pathway:
A novel model and molecular mechanisms of signal transduction. Cell
Mol Life Sci. 73:1317–1332. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruiz i Altaba A, Mas C and Stecca B: The
Gli code: An information nexus regulating cell fate, stemness and
cancer. Trends Cell Biol. 17:438–447. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Wang XQ, Zhang Q, Zhu JY, Li Y,
Xie CF, Li XT, Wu JS, Geng SS, Zhong CY and Han HY:
(−)-Epigallocatechin-3-gallate inhibits colorectal cancer stem
cells by suppressing Wnt/β-catenin pathway. Nutrients. 9:E5722017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu J, Wang S, Chen Y, Li X, Jiang Y, Yang
X, Li Y, Wang X, Meng Y, Zhu M, et al: miR-19 targeting of GSK3beta
mediates sulforaphane suppression of lung cancer stem cells. J Nutr
Biochem. 44:80–91. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Wang X, Xie C, Zhu J, Meng Y, Chen
Y, Li Y, Jiang Y, Yang X, Wang S, et al: Sonic hedgehog and
Wnt/beta-catenin pathways mediate curcumin inhibition of breast
cancer stem cells. Anticancer Drugs. 29:208–215. 2018.PubMed/NCBI
|
|
19
|
Fan PH, Fan SJ, Wang H, Mao J, Shi Y,
Ibrahim MM, Ma W, Yu X, Hou Z, Wang B and Li L: Genistein decreases
the breast cancer stem-like cell population through Hedgehog
pathway. Stem Cell Res Ther. 4:1462013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu D, Shin HS, Lee YS, Lee D, Kim S and
Lee YC: Genistein attenuates cancer stem cell characteristics in
gastric cancer through the downregulation of Gli1. Oncol Rep.
31:673–678. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y and Chen H: Genistein attenuates
WNT signaling by up-regulating sFRP2 in a human colon cancer cell
line. Exp Biol Med (Maywood). 236:714–722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Antosiak A, Milowska K, Maczynska K,
Rozalska S and Gabryelak T: Cytotoxic activity of
genistein-8-C-glucoside form Lupinus luteus L. and genistein
against human SK-OV-3 ovarian carcinoma cell line. Med Chem Res.
26:64–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang W, Wan C and Luo Q, Huang Z and Luo
Q: Genistein-inhibited cancer stem cell-like properties and reduced
chemoresistance of gastric cancer. Int J Mol Sci. 15:3432–3443.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
House CD, Hernandez L and Annunziata CM:
In vitro enrichment of ovarian cancer tumor-initiating cells. J Vis
Exp. Feb 18–2015.doi: 10.3791/52446. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pozzi V, Sartini D, Rocchetti R,
Santarelli A, Rubini C, Morganti S, Giuliante R, Calabrese S, Di
Ruscio G, Orlando F, et al: Identification and characterization of
cancer stem cells from head and neck squamous cell carcinoma cell
lines. Cell Physiol Biochem. 36:784–798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang L, Li L, Jiao M, Wu D, Wu K, Li X,
Zhu G, Yang L, Wang X, Hsieh JT and He D: Genistein inhibits the
stemness properties of prostate cancer cells through targeting
Hedgehog-Gli1 pathway. Cancer Lett. 323:48–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dormoy V, Danilin S, Lindner V, Thomas L,
Rothhut S, Coquard C, Helwig JJ, Jacqmin D, Lang H and Massfelder
T: The sonic hedgehog signaling pathway is reactivated in human
renal cell carcinoma and plays orchestral role in tumor growth. Mol
Cancer. 8:1232009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qian W, Kong X, Zhang T, Wang D, Song J,
Li Y, Li X, Geng H, Min J, Kong Q, et al: Cigarette smoke
stimulates the stemness of renal cancer stem cells via Sonic
Hedgehog pathway. Oncogenesis. 7:242018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Behnsawy HM, Shigemura K, Meligy FY,
Yamamichi F, Yamashita M, Haung WC, Li X, Miyake H, Tanaka K,
Kawabata M, et al: Possible role of sonic hedgehog and
epithelial-mesenchymal transition in renal cell cancer progression.
Korean J Urol. 54:547–554. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mukund V, Mukund D, Sharma V, Mannarapu M
and Alam A: Genistein: Its role in metabolic diseases and cancer.
Crit Rev Oncol Hematol. 119:13–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tirino V, Desiderio V, Paino F, De Rosa A,
Papaccio F, La Noce M, Laino L, De Francesco F and Papaccio G:
Cancer stem cells in solid tumors: An overview and new approaches
for their isolation and characterization. FASEB J. 27:13–24. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Corro C and Moch H: Biomarker discovery
for renal cancer stem cells. J Pathol Clin Res. 4:3–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park EK, Lee JC, Park JW, Bang SY, Yi SA,
Kim BK, Park JH, Kwon SH, You JS, Nam SW, et al: Transcriptional
repression of cancer stem cell marker CD133 by tumor suppressor
p53. Cell Death Dis. 6:e19642015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu J, Cui Y, Zhu J, He J, Zhou G and Yue
Z: Biological characteristics of Rh123high stem-like
cells in a side population of 786-O renal carcinoma cells. Oncol
Lett. 5:1903–1908. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Debeb BG, Zhang X, Krishnamurthy S, Gao H,
Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT, et al:
Characterizing cancer cells with cancer stem cell-like features in
293T human embryonic kidney cells. Mol Cancer. 9:1802010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lichner Z, Saleh C, Subramaniam V,
Seivwright A, Prud'homme GJ and Yousef GM: miR-17 inhibition
enhances the formation of kidney cancer spheres with stem cell/
tumor initiating cell properties. Oncotarget. 6:5567–5581. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mikami S, Mizuno R, Kosaka T, Saya H, Oya
M and Okada Y: Expression of TNF-α and CD44 is implicated in poor
prognosis, cancer cell invasion, metastasis and resistance to the
sunitinib treatment in clear cell renal cell carcinomas. Int J
Cancer. 136:1504–1514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ueda K, Ogasawara S, Akiba J, Nakayama M,
Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M, Matsuoka K and
Yano H: Aldehyde dehydrogenase 1 identifies cells with cancer stem
cell-like properties in a human renal cell carcinoma cell line.
PLoS One. 8:e754632013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Khan MI, Czarnecka AM, Helbrecht I,
Bartnik E, Lian F and Szczylik C: Current approaches in
identification and isolation of human renal cell carcinoma cancer
stem cells. Stem Cell Res Ther. 6:1782015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu FH, Mu L, Li XL, Hu YB, Liu H, Han LT
and Gong JP: Characterization and functional analysis of a
slow-cycling subpopulation in colorectal cancer enriched by cell
cycle inducer combined chemotherapy. Oncotarget. 8:78466–78479.
2017.PubMed/NCBI
|
|
42
|
Giancotti FG: Mechanisms governing
metastatic dormancy and reactivation. Cell. 155:750–764. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tian T, Li J, Li B, Wang Y, Li M, Ma D and
Wang X: Genistein exhibits anti-cancer effects via down-regulating
FoxM1 in H446 small-cell lung cancer cells. Tumour Biol.
35:4137–4145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li S, Li J, Dai W, Zhang Q, Feng J, Wu L,
Liu T, Yu Q, Xu S, Wang W, et al: Genistein suppresses aerobic
glycolysis and induces hepatocellular carcinoma cell death. Br J
Cancer. 117:1518–1528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ardito F, Di Gioia G, Pellegrino MR and
Muzio LL: Genistein as a potential anticancer agent against head
and neck squamous cell carcinoma. Curr Top Med Chem. 18:174–181.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Spagnuolo C, Russo GL, Orhan IE,
Habtemariam S, Daglia M, Sureda A, Nabavi SF, Devi KP, Loizzo MR,
Tundis R and Nabavi SM: Genistein and cancer: Current status,
challenges, and future directions. Adv Nutr. 6:408–419. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ruiz i Altaba A: Hedgehog signaling and
the Gli code in stem cells, cancer, and metastases. Sci Signal.
4:pt92011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rimkus TK, Carpenter RL, Qasem S, Chan M
and Lo HW: Targeting the sonic Hedgehog signaling pathway: Review
of smoothened and GLI inhibitors. Cancers (Basel). 8:E222016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
D'Amato C, Rosa R, Marciano R, D'Amato V,
Formisano L, Nappi L, Raimondo L, Di Mauro C, Servetto A, Fulciniti
F, et al: Inhibition of Hedgehog signalling by NVP-LDE225
(Erismodegib) interferes with growth and invasion of human renal
cell carcinoma cells. Brit J Cancer. 111:1168–1179. 2014.
View Article : Google Scholar : PubMed/NCBI
|
